The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears

A. M. McDermott, D. Rich, James S Cullor, Mark J Mannis, W. Smith, T. Reid, Christopher J Murphy

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background/aims: Pseudomonas aeruginosa is a major cause of severe bacterial keratitis and remains a difficult clinical entity to treat successfully with the current arsenal of antimicrobial agents. Defensins are small cationic peptides with broad in vitro antimicrobial activity and are potential ocular therapeutic agents. The authors characterised the in vitro activity of defensins NP-1 and NP-3a against P aeruginosa in the presence of human tears. Methods: A clinical Pseudomonas isolate was grown to mid-log phase, and 1 × 106 colony forming units were exposed to the peptides (200 μg/ml) for up to 2 hours in the presence of varying concentrations (10-70%) of human tears. Results: For both peptides in the presence of 10% tears, >3 log units of killing was achieved within 30 minutes. In 70% tears, NP-1 produced >1 log unit of killing at 2 hours, indicating that, although reduced, its activity remained significant. In 20% tears, NP-3a demonstrated 2 log units of killing at 2 hours; however, the antimicrobial activity of this defensin was completely inhibited in the presence of 70% tears. Conclusion: These in vitro data suggest that while the microbicidal activity of some defensins may be diminished at the ocular surface in vivo, significant activity is still possible with certain peptides.

Original languageEnglish (US)
Pages (from-to)609-611
Number of pages3
JournalBritish Journal of Ophthalmology
Volume90
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

Defensins
Pseudomonas
Tears
Peptides
Keratitis
Anti-Infective Agents
Pseudomonas aeruginosa
In Vitro Techniques
Stem Cells

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears. / McDermott, A. M.; Rich, D.; Cullor, James S; Mannis, Mark J; Smith, W.; Reid, T.; Murphy, Christopher J.

In: British Journal of Ophthalmology, Vol. 90, No. 5, 05.2006, p. 609-611.

Research output: Contribution to journalArticle

@article{38492ce3d92243008fd2725dce82f8c2,
title = "The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears",
abstract = "Background/aims: Pseudomonas aeruginosa is a major cause of severe bacterial keratitis and remains a difficult clinical entity to treat successfully with the current arsenal of antimicrobial agents. Defensins are small cationic peptides with broad in vitro antimicrobial activity and are potential ocular therapeutic agents. The authors characterised the in vitro activity of defensins NP-1 and NP-3a against P aeruginosa in the presence of human tears. Methods: A clinical Pseudomonas isolate was grown to mid-log phase, and 1 × 106 colony forming units were exposed to the peptides (200 μg/ml) for up to 2 hours in the presence of varying concentrations (10-70{\%}) of human tears. Results: For both peptides in the presence of 10{\%} tears, >3 log units of killing was achieved within 30 minutes. In 70{\%} tears, NP-1 produced >1 log unit of killing at 2 hours, indicating that, although reduced, its activity remained significant. In 20{\%} tears, NP-3a demonstrated 2 log units of killing at 2 hours; however, the antimicrobial activity of this defensin was completely inhibited in the presence of 70{\%} tears. Conclusion: These in vitro data suggest that while the microbicidal activity of some defensins may be diminished at the ocular surface in vivo, significant activity is still possible with certain peptides.",
author = "McDermott, {A. M.} and D. Rich and Cullor, {James S} and Mannis, {Mark J} and W. Smith and T. Reid and Murphy, {Christopher J}",
year = "2006",
month = "5",
doi = "10.1136/bjo.2005.083428",
language = "English (US)",
volume = "90",
pages = "609--611",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears

AU - McDermott, A. M.

AU - Rich, D.

AU - Cullor, James S

AU - Mannis, Mark J

AU - Smith, W.

AU - Reid, T.

AU - Murphy, Christopher J

PY - 2006/5

Y1 - 2006/5

N2 - Background/aims: Pseudomonas aeruginosa is a major cause of severe bacterial keratitis and remains a difficult clinical entity to treat successfully with the current arsenal of antimicrobial agents. Defensins are small cationic peptides with broad in vitro antimicrobial activity and are potential ocular therapeutic agents. The authors characterised the in vitro activity of defensins NP-1 and NP-3a against P aeruginosa in the presence of human tears. Methods: A clinical Pseudomonas isolate was grown to mid-log phase, and 1 × 106 colony forming units were exposed to the peptides (200 μg/ml) for up to 2 hours in the presence of varying concentrations (10-70%) of human tears. Results: For both peptides in the presence of 10% tears, >3 log units of killing was achieved within 30 minutes. In 70% tears, NP-1 produced >1 log unit of killing at 2 hours, indicating that, although reduced, its activity remained significant. In 20% tears, NP-3a demonstrated 2 log units of killing at 2 hours; however, the antimicrobial activity of this defensin was completely inhibited in the presence of 70% tears. Conclusion: These in vitro data suggest that while the microbicidal activity of some defensins may be diminished at the ocular surface in vivo, significant activity is still possible with certain peptides.

AB - Background/aims: Pseudomonas aeruginosa is a major cause of severe bacterial keratitis and remains a difficult clinical entity to treat successfully with the current arsenal of antimicrobial agents. Defensins are small cationic peptides with broad in vitro antimicrobial activity and are potential ocular therapeutic agents. The authors characterised the in vitro activity of defensins NP-1 and NP-3a against P aeruginosa in the presence of human tears. Methods: A clinical Pseudomonas isolate was grown to mid-log phase, and 1 × 106 colony forming units were exposed to the peptides (200 μg/ml) for up to 2 hours in the presence of varying concentrations (10-70%) of human tears. Results: For both peptides in the presence of 10% tears, >3 log units of killing was achieved within 30 minutes. In 70% tears, NP-1 produced >1 log unit of killing at 2 hours, indicating that, although reduced, its activity remained significant. In 20% tears, NP-3a demonstrated 2 log units of killing at 2 hours; however, the antimicrobial activity of this defensin was completely inhibited in the presence of 70% tears. Conclusion: These in vitro data suggest that while the microbicidal activity of some defensins may be diminished at the ocular surface in vivo, significant activity is still possible with certain peptides.

UR - http://www.scopus.com/inward/record.url?scp=33646242748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646242748&partnerID=8YFLogxK

U2 - 10.1136/bjo.2005.083428

DO - 10.1136/bjo.2005.083428

M3 - Article

VL - 90

SP - 609

EP - 611

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 5

ER -